BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16158953)

  • 1. Sabarubicin- (MEN 10755) and paclitaxel show different kinetics in nuclear factor-kappaB (NF-kB) activation: effect of parthenolide on their cytotoxicity.
    Bellarosa D; Binaschi M; Maggi CA; Goso C
    Anticancer Res; 2005; 25(3B):2119-28. PubMed ID: 16158953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo.
    Zhang D; Qiu L; Jin X; Guo Z; Guo C
    Mol Cancer Res; 2009 Jul; 7(7):1139-49. PubMed ID: 19584264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inositol hexaphosphate and paclitaxel: symbiotic treatment of oral cavity squamous cell carcinoma.
    Janus SC; Weurtz B; Ondrey FG
    Laryngoscope; 2007 Aug; 117(8):1381-8. PubMed ID: 17607147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the genes involved in enhanced fenretinide-induced apoptosis by parthenolide in human hepatoma cells.
    Park JH; Liu L; Kim IH; Kim JH; You KR; Kim DG
    Cancer Res; 2005 Apr; 65(7):2804-14. PubMed ID: 15805281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest.
    Dziadyk JM; Sui M; Zhu X; Fan W
    Anticancer Res; 2004; 24(1):27-36. PubMed ID: 15015572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
    Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells.
    Riganti C; Doublier S; Costamagna C; Aldieri E; Pescarmona G; Ghigo D; Bosia A
    Mol Pharmacol; 2008 Aug; 74(2):476-84. PubMed ID: 18463201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest.
    Ralstin MC; Gage EA; Yip-Schneider MT; Klein PJ; Wiebke EA; Schmidt CM
    Mol Cancer Res; 2006 Jun; 4(6):387-99. PubMed ID: 16778086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model.
    Kang HJ; Lee SH; Price JE; Kim LS
    Breast J; 2009; 15(3):223-9. PubMed ID: 19645775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of NF-kappaB activation in a H4IIE transfectant insensitive to doxorubicin-induced apoptosis.
    Chovolou Y; Wätjen W; Kampkötter A; Kahl R
    Toxicology; 2007 Mar; 232(1-2):89-98. PubMed ID: 17223244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1'S-1'-acetoxyeugenol acetate: a novel phenylpropanoid from Alpinia conchigera enhances the apoptotic effects of paclitaxel in MCF-7 cells through NF-κB inactivation.
    In LL; Azmi MN; Ibrahim H; Awang K; Nagoor NH
    Anticancer Drugs; 2011 Jun; 22(5):424-34. PubMed ID: 21346553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-alpha induces transient resistance to Fas-induced apoptosis in eosinophilic acute myeloid leukemia cells.
    Qin Y; Auh S; Blokh L; Long C; Gagnon I; Hamann KJ
    Cell Mol Immunol; 2007 Feb; 4(1):43-52. PubMed ID: 17349210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Apoptotic effect of the combined treatment of engineered antibody with paclitaxel on BT474 cells].
    Yin HJ; Cheng LS; Duan JL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Mar; 23(3):260-3. PubMed ID: 17343796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells.
    Vadgama JV; Wu Y; Shen D; Hsia S; Block J
    Anticancer Res; 2000; 20(3A):1391-414. PubMed ID: 10928049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK; Wan CK; Shen XL; Yang M; Fong WF
    Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin synergizes the growth inhibitory properties of Indian toad (Bufo melanostictus Schneider) skin-derived factor (BM-ANF1) in HCT-116 colon cancer cells.
    Giri B; Gomes A; Sengupta R; Banerjee S; Nautiyal J; Sarkar FH; Majumdar AP
    Anticancer Res; 2009 Jan; 29(1):395-401. PubMed ID: 19331178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of urokinase receptor expression by thalidomide is associated with inhibition of nuclear factor kappaB activation and subsequently suppressed ovarian cancer dissemination.
    Kobayashi H; Yagyu T; Kondo T; Kurita N; Inagaki K; Haruta S; Kawaguchi R; Kitanaka T; Sakamoto Y; Yamada Y; Kanayama N; Terao T
    Cancer Res; 2005 Nov; 65(22):10464-71. PubMed ID: 16288038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo.
    Kanai K; Kikuchi E; Mikami S; Suzuki E; Uchida Y; Kodaira K; Miyajima A; Ohigashi T; Nakashima J; Oya M
    Cancer Sci; 2010 Jan; 101(1):216-23. PubMed ID: 19824995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel efficacy is increased by parthenolide via nuclear factor-kappaB pathways in in vitro and in vivo human non-small cell lung cancer models.
    Gao ZW; Zhang DL; Guo CB
    Curr Cancer Drug Targets; 2010 Nov; 10(7):705-15. PubMed ID: 20578985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parthenolide, an NF-κB inhibitor, suppresses tumor growth and enhances response to chemotherapy in gastric cancer.
    Sohma I; Fujiwara Y; Sugita Y; Yoshioka A; Shirakawa M; Moon JH; Takiguchi S; Miyata H; Yamasaki M; Mori M; Doki Y
    Cancer Genomics Proteomics; 2011; 8(1):39-47. PubMed ID: 21289336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.